glp-1 colorectal cancer death risk study november 2025 mortality If you are taking a GLP-1 for diabetes or weight loss, a new study found it may also be lowering GLP-1s Tied to Big Survival

For weight management , NICE technology appraisal guidance supports semaglutide 2.4 mg (Wegovy) for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 30 kg/m in exceptional circumstances), as part of a specialist weight management service

A phase 1 proof-of-concept clinical trial was conducted in 53 people with T2DM and translated the favorable preclinical data into clinical facts

Efficacy and safety of tirzepatide in type 2 diabetes and obesity management

Many people find that the reduced appetite leads to smaller meals, which can actually ease digestion

Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission

Over the past few years, GLP-1 medications have fundamentally changed how we think about metabolic health